A novel composite endpoint of toxicity and PFS in patients with R/R FL treated with axi-cel
Razan Mohty, MD, Moffitt Cancer Center, Tampa, FL, summarizes the key points of a study evaluating a novel composite endpoint of toxicity and progression-free survival (PFS) in patients with relaps...
vjhemonc.com